Honored to have been a part of this amazing meeting. Sincere thanks to the Turkish Society of Hematology and ASH for organizing. Was wonderful to see old friends and meet new colleagues! @NitinJainMD @kristenpettitmd
Replying to @CemreSucubulak
thank you so much!
and also many thanks to all experts coming for the ASH Highlights in the Mediterranean including @NitinJainMD @myeloidmalig @kristenpettitmd @Geoff_Uy @ECurranMD @DrLaCasce @DrMonzrAlMalki @SwapnaThota and more 🙏
@ASH_hematology
➡️hematology.org/meetings/high…
Emily Curran retweeted
Replying to @CemreSucubulak
thank you so much!
and also many thanks to all experts coming for the ASH Highlights in the Mediterranean including @NitinJainMD @myeloidmalig @kristenpettitmd @Geoff_Uy @ECurranMD @DrLaCasce @DrMonzrAlMalki @SwapnaThota and more 🙏
@ASH_hematology
➡️hematology.org/meetings/high…
Emily Curran retweeted
We look forward to welcoming our first Foley Family Fellow in Leukemia in one year! Apply to the
tinyurl.com/Leukemia-Fellows… by Aug 15. @DanaFarber.
The @DanaFarber Div of Leukemia is thrilled to launch the Foley Family Fellowship in Leukemia! Apply to join us for clinical and clinical/transl. research training jobcenter.hematology.org/job…
@lane_andy @Lachelle_Dawn @Chris_R_Reilly @ColemanLindsley @TothovaLab and so many others.
Emily Curran retweeted
Replying to @LuskinMarlise
@LuskinMarlise @ECurranMD nothing makes me happier than the opportunity to speak alongside both of you!
Excited to be at #ASCO22 and truly honored to join chair @ECurranMD and @LoriMuffly for an Ed Session on Innovative Approaches to Acute Lymphoblastic Leukemia Across the Age Spectrum. 445 CDT E450. meetings.asco.org/abstracts-…
Emily Curran retweeted
Replying to @ECurranMD
@ECurranMD + @KSchmiegelow are presenting new approaches to optimize #asparaginase therapy in the mgmt of #acute #lymphoblastic #leukemia Sunday morning June 5 in Chicago and virtually online #ASCO22 💻 Register for free➡️tinyurl.com/45rrecp3
Best part of ASH is always seeing old friends! Such a wonderful and inspiring group of people. Can’t wait until next year!
#ASH21 the Dr. Stock @myeloidmalig @SoniSmithMD mentee crew (missing many!) @ECurranMD @LoriMuffly @CanerSaygin @AfafOsman7
5
Emily Curran retweeted
Comparison of CALGB 10403 (Alliance) and COG AALL0232 toxicity results in young adults with acute lymphoblastic leukemia ow.ly/MG8l50Dg1S8 #ALL #leusm
Emily Curran retweeted
Replying to @FertilityNP
@FertilityNP Thanks for mentioning @BradZebrack and @DrAnneKatz as speakers for the NCH/OSU AYA Symposium! Adding @DrLeslieAppiah @SarahSeeAYA @BLockwoodMD @ECurranMD @KarenMoody @mroth_MD, Mitch Cairo and Sam Hulett to round out our amazing speaker lineup! #pedsmedchat #ayascm
Emily Curran retweeted
This is a worrisome trend. Cancer incidents in young adults increasing. Trends in Cancer Incidence in US Adolescents and Young Adults, 1973-2015 jamanetwork.com/journals/jam…
Emily Curran retweeted
We spoke with Wendy Stock, 2020 @ASH_hematology Mentor Award recipient for clinical medicine, about the joy of cultivating the next generation of clinicians and researchers #ASH20 ashclinicalnews.org/spotligh…
Such an inspiration to so many mentees, especially female hematologists. She is an amazing scientist, physician, mother, and friend - showing us all that this can be possible. So honored to be a part of the “Wendy Stock fan club” #ASHKudos #SHEmatology @HemOncWomenDocs
Wendy Stock, MD, of @UChicago, with the 2020 ASH Mentor Award for contributing to the professional development of #hematology trainees at various stages in their careers.
Say #ASHKudos and watch her entire speech on the #ASH20 platform.
Emily Curran retweeted
Dasatinib–Blinatumomab for Ph-Positive Acute Lymphoblastic Leukemia in Adults | NEJM nejm.org/doi/full/10.1056/NE…
Emily Curran retweeted
Congrats to our own @UCHealthNews, @TMWiseDraper for being high lighted by @OncJournal @DavendraSohal @kharofaJ @UCResearch
So excited to open this trial at @uc_health
.@uc_health in Cincinnati is now enrolling patients with acute myeloid #leukemia (#AML) w/ a FLT3 mutation in clinical trial PrE0905. Learn more: https://xitter.gq/t.co/6Zx1NaiANq #leusm cc: @ECurranMD
Emily Curran retweeted
Throwback to an article by @AmyWangDuncanMD with mentorship from the leukemia and trasnsplant faculty at @UCCancerCenter looking at toxicities of nivolumab after allo-transplant!
pubmed.ncbi.nlm.nih.gov/3201…
Emily Curran retweeted
I felt a lot of #ImposterSyndrome writing my Oct @ASCO Connection column! But it was about my journey so far as a #ClinicianEducator and where I hope to go from here. Here are some tips that I wanted to share. Please share yours #MedTwitter!
connection.asco.org/blogs/de…
Emily Curran retweeted
His legacy looms large - trained hundreds if not thousands of housestaff. Just the other day, a patient reminisced how Dr. Baron diagnosed him when nobody else could. A master diagnostician and one of the kindest and warmest people I knew. May his memory be a blessing.
In memory of Dr Joe Baron: medicine.uchicago.edu/joseph…
Emily Curran retweeted
My latest #ASCODailyNews article on the persistent #disparities in #cancercare, current challenges and emerging strategies. Much work remains to ensure #equity.
@ASCO @ASCO_pubs @ASCOPres @uc_health #MedTwitter #AcademicTwitter #ASCO20
1/
dailynews.ascopubs.org/do/10…
Emily Curran retweeted
We love to see our faculty like @TMWiseDraper making the @ASCO Evening Post. New findings about cancer treatment and COVID-19. Read about it here. #UCResearch
click.email.hbside.com/?qs=f…

































